Wonbufenprimixture Injection (Ibuprofen)
Ibuprofen 400mg
Injections · Prescription medication
Hana Pharmaceutical Co., Ltd.
MFDS item code 202202363 · Notified 2022.06.07
Adjunctive therapy to opioid analgesics for moderate to severe pain; reduction of fever
This medication is used as an adjunct therapy with opioid analgesics to manage moderate to severe pain. Additionally, it aids in reducing discomfort for patients with fever by providing an antipyretic effect. Therefore, it is effectively used for pain relief and temperature control.
Administer the lowest effective dose of this medicine that meets the treatment goals of each patient for the shortest duration. After the initial dose, adjust the dose and frequency of administration appropriately according to the patient's condition. This medicine is a premixed preparation and must be administered undiluted. Use only when one unit package per dose (ibuprofen 400mg or 800mg) can replace the required dose; do not divide the contents for use. Adults may receive up to 3200mg per day. To reduce the risk of renal adverse reactions, ensure that the patient is adequately hydrated before administration. (1) Adjunctive therapy to opioid analgesics (morphine) for the management of moderate to severe pain ⦁ Adults (17 years and older): Administer 400mg-800mg intravenously every 6 hours as needed. Up to 3200mg per day may be administered. The administration time must be at least 30 minutes. (2) Fever reduction ⦁ Adults (17 years and older): Administer 400mg intravenously every 4-6 hours as needed. Depending on the patient's condition, 100-200mg may also be administered every 4 hours after an initial dose of 400mg. Up to 3200mg per day may be administered. The administration time must be at least 30 minutes.
6 months to under 12 years: Administer 10mg/kg per dose (up to a maximum of 400mg) intravenously every 4~6 hours as needed. The administration time must be at least 10 minutes. Up to 40mg/kg or 2,400mg per day may be administered (whichever dose is lower). 12 years to under 17 years: Administer 400mg per dose intravenously every 4~6 hours as needed. The administration time must be at least 10 minutes. Up to 2,400mg per day may be administered.
This medication may increase the risk of serious cardiovascular problems such as myocardial infarction and stroke in patients with cardiovascular disease or risk factors. It can cause serious gastrointestinal adverse reactions such as gastrointestinal bleeding, ulcers, and perforation, especially in the elderly or long-term users who need to be more cautious. Patients with a history of gastrointestinal ulcers or bleeding, severe blood, liver, kidney, or heart disease, and those allergic to this medication should not use it. Patients with a history of bronchial asthma or hypersensitivity to aspirin and other non-steroidal anti-inflammatory drugs should not take this medication. In late pregnancy, the risk of premature closure of the ductus arteriosus in the fetus exists, so this medication should not be used. Patients undergoing high-dose methotrexate chemotherapy should also avoid it. Care should be taken when administering this medication to patients with specific conditions such as blood disorders, liver or kidney function impairment, hypertension, heart failure, and especially in the elderly, pregnant, and nursing women. Adverse reactions should be closely monitored during treatment, and if skin rash, breathing difficulties, or severe gastrointestinal symptoms occur, use should be immediately discontinued and medical consultation sought. This medication should not be taken with other non-steroidal anti-inflammatory drugs, and interactions may occur when taken with aspirin, anticoagulants, ACE inhibitors, diuretics, lithium, methotrexate, etc., so patients must inform healthcare professionals of any other medications they are taking. Pregnant women are particularly advised to avoid use after mid-pregnancy, and in nursing women, the medication may pass through breast milk, leading to adverse reactions in the baby; therefore, breastfeeding should be discontinued or medication use avoided. This medication should not be used in children under 6 months of age, as safety and efficacy have not been established, and in the elderly, dose adjustment and monitoring may be necessary due to decreased body function. In cases of overdose, serious symptoms such as dizziness, nausea, vomiting, liver function abnormalities, kidney failure, breathing difficulties, and hypotension may occur, so the dosage must be strictly adhered to, and in cases of overdose, use should be immediately discontinued, and medical treatment sought.
Shock, anaphylactic reaction, mimicry concern, chills, dyspnea, hypotension, decreased hematocrit, decreased hemoglobin, anemia, aplastic anemia, hemolytic anemia, agranulocytosis, granulocytopenia, leukopenia, thrombocytopenia, impaired platelet function, eosinophilia, peptic ulcer, gastrointestinal ulcer, gastrointestinal bleeding, perforation, ulcerative colitis, blood in stool, gastritis, pancreatitis, hematemesis, Crohn's disease, loss of appetite, nausea, vomiting, abdominal pain, dyspepsia, diarrhea, discomfort in the upper stomach, epigastric pain, thirst, stomatitis, abdominal distension, oral ulcer, constipation, black stool, mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, photosensitivity reaction, drug rash with eosinophilia and systemic symptoms, angioedema, bullous dermatitis, erythema multiforme, papular rash, skin redness, vesicles, rash, exfoliative dermatitis, acute generalized exanthematous pustulosis, hepatitis, jaundice, elevated GOT, elevated GPT, elevated alkaline phosphatase, abnormal liver function, hepatic impairment, hypersensitivity, anaphylactic reaction, asthma attack, urticaria, eczema, purpura, rash, pruritus, asthma, bronchoconstriction, dyspnea, wheezing, scotoma, hearing loss, tinnitus, altered taste, dizziness, drowsiness, lightheadedness, depression, headache, cerebrovascular accident, irritability, aseptic meningitis, meningitis, increased blood pressure, palpitations, heart failure, myocardial infarction, angina, acute renal failure, oliguria, hematuria, proteinuria, elevated BUN, elevated serum creatinine, hyperkalemia, interstitial nephritis, nephritic syndrome, renal papillary necrosis, decreased urine output, generalized edema, shortness of breath, lethargy, Conn's syndrome, periorbital edema, facial edema, fatigue, fever, epistaxis, edema, peripheral edema, nausea, vomiting, abdominal distension, headache, hemolysis, drowsiness, peripheral edema, urinary disturbance, anemia, decreased hemoglobin, dyspepsia, wound hemolysis, abdominal discomfort, cough, hypokalemia, anemia, eosinophilia, hypoalbuminemia, neutropenia, increased hematuria, hypernatremia, hypertension, hypoalbuminemia, hypotension, diarrhea, bacterial pneumonia, elevated serum LDH, thrombocytosis, septicemia, injection site pain, nausea, dizziness, abdominal pain, abnormal liver function, hyperkalemia, metabolic acidosis, drowsiness, loss of consciousness, seizures, renal failure, dyspnea, respiratory depression, hypotension
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent contact with air, preferably at a temperature between 1 degree and 30 degrees Celsius (room temperature). Storing it this way helps maintain the effectiveness of the drug and prevents degradation.
A colorless or light yellow liquid filled in a colorless transparent plastic container injection.
100 milliliters/vial, 200 milliliters/vial
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ibuprofen 400mg
Injections · Prescription medication
Hana Pharmaceutical Co., Ltd.

Ibuprofen 200mg
Tablet · OTC medication
Samil Pharmaceutical Co., Ltd.

Ibuprofen 400mg
Tablet · OTC medication
Samil Pharmaceutical Co., Ltd.

Ibuprofen 400mg
Tablet · OTC medication
(Company) AProgen Biologics
Ibuprofen 200mg
Tablet · OTC medication
Taeguk Pharmaceutical Co., Ltd.
Ibuprofen 400mg
OTC medication
Youngpoong Pharmaceutical Co., Ltd.
Ibuprofen 2g
Suspension · OTC medication
Samil Pharmaceutical Co., Ltd.
Ibuprofen 2g
Suspension · OTC medication
Il Dong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.